Stay updated with breaking news from Thorium Express Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some 75-100 times more doses of next generation alpha targeted therapy treatments will be available annually worldwide, compared with today, through a project to produce isotopes from legacy nuclear material at the US Department of Energy's Oak Ridge National Laboratory, the project partners say.
A two-year effort by Oak Ridge Office of Environmental Management and contractor Isotek to process and dispose of a low-dose inventory of uranium-233 stored at the US Department of Energy's Oak Ridge National Laboratory in Tennessee has been completed. As well as eliminating legacy nuclear material the effort has also provided nuclear isotopes for next-generation cancer treatment research.